Medicines
Shortlist up to four to read them side by side.
704 medicine recalls FDA’s Enforcement Report published in 2026, the newest year, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
704of 704 medicine recallsshown with your filters
The list
- Medicine recall Levothyroxine Sodium Tablets, USP, 100 mcg Subpotent Drug Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Levothyroxine Sodium Tablets, USP, 112 mcg Subpotent Drug Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Levothyroxine Sodium Tablets, USP, 125 mcg Subpotent Drug Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Levothyroxine Sodium Tablets, USP, 137 mcg Subpotent Drug Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Levothyroxine Sodium Tablets, USP, 150 mcg Subpotent Drug Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Levothyroxine Sodium Tablets, USP, 175 mcg Subpotent Drug Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Levothyroxine Sodium Tablets, USP, 200 mcg Subpotent Drug Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Levothyroxine Sodium Tablets, USP, 300 mcg Subpotent Drug Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Clobetasol Propionate Cream USP, 0.05%, 60 g tube Failed content uniformity specifications. Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Zicam, Cold Remedy, Medicated Nasal Swabs, With Cooling Menthol & Eucalyptus, 20 Single-Use Swabs per carton,… CGMP Deviations; FDA inspection of the contract manufacturer noted out of limit results for microbiological testing Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Acthar Gel (repository corticotropin injection), 5 mL multiple-dose vial Presence of particulate matter: glass and stopper piece Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Paxil CR, Paroxetine, Extended-Release Tablets, 37.5mg, 30 count bottle Failed Dissolution Specifications; product failed to meet 24-month stability testing acceptance criteria Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Tyenne (tocilizumab-aazg) Injection, 400 mg/20 mL Presence of particulate matter:An internal investigation at the firm found the product to contain glass particles. FDA Class I, its most serious class Class IFDA’s class (needs attention)Sep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IStatusOngoingWhereNationwide
- Medicine recall Ramipril Capsules USP, 10 mg Failed Impurities/Degradation Specifications: OOS result obtained for a process impurity, dicyclohexylurea (DCU). Class IIFDA’s classSep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Lactated Ringer’s Injection USP, 1000 mL EXCEL container Presence of Particulate matter. FDA Class I, its most serious class Class IFDA’s class (needs attention)Sep 2, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedSep 2, 2026ClassClass IStatusOngoingWhereNationwide
- Medicine recall PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL Discolored solution. Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall PEMRYDI RTU(pemetrexed injection), 500 mg/50 mL Discolored solution. Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Libtayo (cemiplimab-rwlc) Injection, 350 mg/7 mL Lack of Assurance of Sterility Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Carbamazepine Tablets, USP, 200mg, 1000 count bottles CGMP Deviations; black spots found on tablets from burnt excipient during manufacturing Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Carbamazepine Tablets, USP, 200mg CGMP deviations: tablets with black specks. Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Acamprosate Calcium, Delayed-Release Tablets, 333 mg, 180 tablets bottles Failed Dissolution Specifications Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Morphine Sulfate Injection, USP, 2 mg /mL, 1 mL single-dose Simplist prefilled syringes, For Intramuscular or… Labeling: Label Mixup: MicroVault labeled as Morphine 2 mg/1 mL, contains a Prefilled Syringe of Dilaudid 0.5 mg/0.5 mL. FDA Class I, its most serious class Class IFDA’s class (needs attention)Aug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IStatusOngoingWhereNationwide
- Medicine recall Nitroglycerin injection, USP, 50 mg/10 mL Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Cyanocobalamin injection USP, 1,000 mcg/mL, For IM or SC Use Only Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Cyanocobalamin injection USP, 10,000 mcg/10 mL Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall AMINAOCAPROIC ACID INJECTION, USP, 250 mg/mL Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Atropine Sulfate injection, USP, 1 mg/mL, For intravenous Use, Sterile Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall ACETYLCYSTEINE SOLUTION, USP, 10% Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall ACETYLCYSTEINE SOLUTION, USP, 20% Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Selenious Acid Injection, USP 12 mcg/2 mL Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Multrys (Trace Elements Injection 4, USP), For intravenous infusion Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Papaverine HCl Injection, USP, 60 mg/2 mL Presence of Particulate Matter: Product contaminated with particulate matter identified as glass and/or paraformaldehyde FDA Class I, its most serious class Class IFDA’s class (needs attention)Aug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IStatusOngoingWhereNationwide
- Medicine recall Tralement (trace elements injection 4*, USP) Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall niCARdipine Hydrochloride Injection, USP, 25 mg/10mL Presence of Particulate Matter: Product contaminated with particulate matter identified as hair, glass and/or paraformaldehyde Class IIFDA’s classAug 26, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 26, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall Diovan (valsartan) 160 mg, 90 tablets Failed Dissolution Specifications Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall SEMAGLUTIDE 12.5MG Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall SEMAGLUTIDE 2.25MG Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall SEMAGLUTIDE 6.75mg Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall SEMAGLUTIDE 4.5mg Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall SEMAGLUTIDE 9mg Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall SEMAGLUTIDE 0.9mg Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall SEMAGLUTIDE 2.5mg Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall SEMAGLUTIDE 5mg Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall SEMAGLUTIDE 7.5mg Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall SEMAGLUTIDE 10mg Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall SEMAGLUTIDE 20mg Presence of Particulate Matter; identified as a nylon/polyamide and silk/proteinaceous-type material Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall SILDENAFIL CITRATE USP, 0.100 KG, 100 gm-bag CGMP Deviations:Noted during FDA inspection Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
- Medicine recall TADALAFIL USP, 0.100 KG, 0.1KG(100gm)-bag CGMP Deviations:Noted during FDA inspection Class IIFDA’s classAug 19, 2026in FDA’s Enforcement ReportNationwideFDA’s word for where it went PublishedAug 19, 2026ClassClass IIStatusOngoingWhereNationwide
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.